New Cross-Study Analysis from Spherix Global Insights Combines Physician, Dietitian and Patient Chart Data to Show Access Barriers Still Curbing Xphozah Uptake Ahead of the TDAPA Cliff

Summary

Spherix Global Insights published a cross-study analysis showing that access barriers continue to limit Xphozah uptake ahead of the TDAPA cliff, based on physician, dietitian, and patient chart data.